Imbruvica (ibrutinib) is a targeted therapy used in chronic lymphocytic leukaemia, mantle cell lymphoma and other blood cancers — and one of the most expensive medicines a patient can be prescribed. If you are facing the cost out of pocket, here is what it actually costs and where the savings are.
How much does Imbruvica cost per month?
Pricing varies by country and insurance, but indicatively the branded originator costs around US$14,000–18,000 per month in the United States before any cover, with lower and often subsidised prices in the UK and Australia. Over a year of continuous treatment, that runs into six figures.
Why is Imbruvica so expensive?
Imbruvica is protected by patents, so there is little price competition. The originator price reflects the cost of the research, clinical trials and global marketing that brought ibrutinib to market — costs recovered during the patent-protected period.
Imbruvica cost without insurance
Without insurance or a reimbursement scheme, the full list price falls on the patient, which for many people is unaffordable. That is why patients and carers search for lower-cost routes — patient-assistance programmes, and above all the licensed generic.
How to pay less: generic Ibrutinib
The single biggest lever on cost is the generic. Generic Ibrutinib contains the same active ingredient as branded Imbruvica, produced by licensed pharmaceutical manufacturers, typically at a small fraction of the originator price. See the full side-by-side breakdown, strengths and current pricing on our generic Imbruvica (Ibrutinib) page, or browse all Ibrutinib products. A valid prescription is required and every order is reviewed by a licensed pharmacist before dispatch. Used as prescribed by a licensed medical professional.
Frequently asked questions
How much does Imbruvica cost per month?
Branded Imbruvica is one of the most expensive blood-cancer medicines — indicatively around US$14,000–18,000 a month in the United States before insurance, with UK and Australian prices lower and often subsidised. Exact prices vary by dose and country.
Why is Imbruvica so expensive?
It is a patent-protected targeted therapy for chronic lymphocytic leukaemia and other blood cancers. The originator price reflects research, trials and marketing under patent protection, with little price competition.
Is there a generic version of Imbruvica?
Generic ibrutinib contains the same active ingredient at the same strengths and is produced by licensed pharmaceutical manufacturers. Discuss any switch between brand and generic with your prescribing doctor.
How much cheaper is generic ibrutinib?
Generic ibrutinib is typically a small fraction of the branded price. Exact savings depend on country, strength and pack size — see our generic Imbruvica page for current pricing.
This article is general information, not medical or financial advice. Prices are indicative and vary by country, pack size, insurance and over time. Always use any medicine as prescribed by a licensed medical professional.
Shah Sam Riddhi is a licensed clinical pharmacist with 9 years of experience. She holds a B.Pharm and M.Pharm from Gujarat University. At OnlineMeds, she reviews medicine and health content to help ensure it is accurate, evidence-based, and easy to understand.